Full-Time
Clinical Customer Success Executive
Confirmed live in the last 24 hours
Hippocratic AI
51-200 employees
Develops specialized language models for healthcare
No salary listed
Senior
Palo Alto, CA, USA + 1 more
More locations: York, PA, USA
Get referrals →
You have ways to get a Hippocratic AI referral from your network.
Applications through a referral are 3x more likely to get an interview!
Upload your resume to see how it matches 5 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
- A minimum of 5 years of clinical experience or health system exposure.
- Proven experience in customer success, account management, or project management.
- Ability to build relationships across an organization, from front-line staff to executives.
- Strong understanding of the healthcare industry, specifically clinical workflows and regulatory requirements.
- Experience working with cross-functional teams in a fast-paced startup environment.
- Strong background in project management.
- This is a remote position, but frequent travel and onsite presence with clients will be expected.
- Build and maintain strong relationships with healthcare staff and operational leaders, acting as a trusted clinical resource.
- Lead product implementations, focusing on aligning solutions with nursing workflows and operational processes.
- Train nursing teams and other healthcare staff on the effective use of Hippocratic AI solutions, ensuring adoption and success.
- Identify opportunities to improve workflows and patient care outcomes using AI tools, particularly in bedside care and nursing operations.
- Manage day-to-day client relationships, ensuring seamless communication and addressing operational concerns.
- Collaborate with internal teams (product, sales, and engineering) to address client feedback and improve user experiences.
- Establish metrics to measure success, including patient care outcomes, team adoption rates, and operational efficiencies.
- Travel extensively to healthcare facilities for onsite support and training, and participate in strategic in-office sessions in Palo Alto.
- Collaborate with the nursing leadership team to share best practices from AI implementation and be comfortable presenting at conferences/webinars on the impact of AI in Nursing.
- Experience with AI or technology adoption in healthcare.
- Advanced knowledge of healthcare workflows and compliance standards.
- Active Registered Nurse (RN) license from an accredited university.
Hippocratic AI develops advanced language models specifically designed for healthcare applications. Their models are tailored to improve healthcare access, equity, and outcomes by focusing on safety and reliability for non-clinical tasks. The company has created a model that has outperformed GPT-4 in 105 out of 114 healthcare exams, showcasing its accuracy. Hippocratic AI serves hospitals, clinics, and healthcare providers, offering AI solutions that enhance patient care and operational efficiency. Unlike general-purpose models, Hippocratic AI's models are trained on evidence-based healthcare content and validated through a process that includes feedback from healthcare professionals. The company generates revenue through licensing its models, forming partnerships with healthcare organizations, and potentially offering subscription services for ongoing support. Their goal is to provide safe, effective, and compassionate AI interactions in the healthcare sector.
Company Size
51-200
Company Stage
Series B
Total Funding
$276M
Headquarters
Palo Alto, California
Founded
2022
Simplify's Take
What believers are saying
- Raised $141 million in Series B funding, indicating strong investor confidence.
- Partnership with EUCALIA expands their reach into the Japanese healthcare market.
- AI agent app store launch allows for greater customization in healthcare systems.
What critics are saying
- Cultural and language barriers may affect adoption in the Japanese market.
- Rapid expansion post-funding could lead to strategic misalignment.
- Intense competition from companies like Qventus and LeanTass may impact market share.
What makes Hippocratic AI unique
- Hippocratic AI specializes in healthcare-specific language models, unlike general-purpose LLMs.
- Their models outperform GPT-4 in 105 out of 114 healthcare exams.
- The Polaris Constellation System ensures high empathy and medical accuracy in AI interactions.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Flexible Work Hours
Growth & Insights and Company News
6 month growth
↑ 4%1 year growth
↓ -1%2 year growth
↓ -7%Hippocratic AI, a generative AI company developing safety-focused large language models for healthcare, has partnered with EUCALIA, a healthcare transformation company, to launch the first Japanese-language genAI healthcare agent for non-diagnostic, patient-facing clinical tasks.
What You Should Know:– Hippocratic AI, the global leader in safety-focused generative AI agents for healthcare, today announced a partnership with EUCALIA Inc., a Tokyo-based healthcare transformation company focused on optimizing clinical operations and advancing care delivery, to launch the first Japanese-language generative AI healthcare agent for non-diagnostic, patient-facing clinical tasks.– This marks Hippocratic AI’s entry into the Japanese market, further advancing its global mission to deliver healthcare abundance through technology.Hippocratic AI and EUCALIA Partner to Launch Japan’s First Safety-Focused Generative AI Healthcare AgentHippocratic AI has partnered with EUCALIA to introduce a generative AI healthcare agent in Japan, designed to enhance patient access and ease clinician workload in a healthcare system facing rising demand, an aging population, and workforce constraints. The agent will handle essential, non-diagnostic, patient-facing responsibilities—including appointment scheduling, medication adherence support, chronic care check-ins, and follow-up outreach—enabling clinicians to focus on core care tasks.At the core of this solution is Hippocratic AI’s Polaris Constellation System, a patented safety-first architecture built specifically for high-empathy, medically accurate conversations. The system has:Powered over 1.85 million patient calls in the U.S.Achieved a clinical accuracy rate of 99.38%Reached a patient experience rating of 8.95/10Been adopted by more than 25 enterprise healthcare partnersThis architecture includes a series of specialized supervisor models that oversee medication discussions, lab results, nutrition, vitals, escalation protocols, and hospital-specific policies—ensuring safe and tailored patient engagement at scale.The collaboration builds on Hippocratic AI’s founding mission to bring healthcare expertise to every human through safe, accessible AI. Co-founded by CEO Munjal Shah alongside clinicians, hospital administrators, and AI experts from institutions like Stanford, Johns Hopkins, Microsoft, and NVIDIA, the company has focused on setting new global standards for clinical AI safety.“This partnership with EUCALIA reflects our commitment to building generative AI agents that are not just multilingual but locally fluent, clinically safe, and culturally aligned,” said Shah. “Together, we aim to deliver meaningful improvements in patient outcomes, clinical operations, and system resilience.”By combining Hippocratic AI’s robust technology with EUCALIA’s local healthcare insight, the partnership aims to create a scalable, culturally competent solution that enhances efficiency, empathy, and accessibility across Japan’s healthcare landscape
Hippocratic AI, the global leader in safety-focused generative AI agents for healthcare, today announced a partnership with EUCALIA Inc., a Tokyo-based healthcare transformation company focused on optimizing clinical operations and advancing care delivery, to launch the first Japanese-language generative AI healthcare agent for non-diagnostic, patient-facing clinical tasks.
Abu Dhabi: Burjeel Holdings today announced a strategic partnership with Hippocratic AI, the company that pioneered the first safety-focused generative AI healthcare agents, to transform healthcare delivery through safe, scalable, and empathetic AI.
In Q1 2025, digital health startups raised $3 billion, up from $2.7 billion in Q1 2024, with 122 deals. Average deal size increased to $24.4 million. Early-stage rounds dominated, with Hippocratic AI raising $141 million in a series B. Late-stage funding returned with megadeals like Innovaccer's $275 million. The market faces uncertainty due to policy changes, but companies are leveraging M&A and channel partnerships to adapt. Hinge Health's IPO plans are uncertain amid market volatility.